All In MedTech

Device Trial Radar · NCT05057975

Validation of an Integrated Digital Solution (SUNrise®) Versus Polysomnography for Obstructive Sleep Apnea Diagnosis

Validation d'Une Solution Digitale intégrée (SUNrise®) d'Analyse Automatique Des Mouvements Mandibulaires Par Intelligence Artificielle Versus Polysomnographie Pour le Diagnostic du Syndrome d'Apnées Obstructives du Sommeil

Last checked: Nov 19, 2026Latest source record: Dec 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 848 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

848

Actual

Start

Oct 28, 2021

Primary completion

Oct 7, 2024

Study completion Oct 7, 2024

Sponsor

Lead sponsor
SunriseNot on our public-company list
Sponsor type
Industry
Collaborators
ICUREsearch
First posted
Sep 27, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Validation of an integrated digital solution (SUNrise®) of mandibular movement automatic analysis by artificial intelligence versus polysomnography for obstructive sleep apnea diagnosis: a prospective, randomized, parallel-arm, open-label, multicenter, national, controlled study.

Conditions

  • Obstructive Sleep Apnea

Interventions

  • SunriseDevice

    Use of the Sunrise device for three nights to register mandibular movements that will be automatically analysed using artificial intelligence.

  • polysomnographyDevice

    Reference protocol to diagnose OSA (in-lab or outpatient PSG)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in daily sleepinessTime frame: 3 months post-diagnosis
  2. Time to diagnosisTime frame: Up to 12 months
  3. Time to treatmentTime frame: Up to 15 months

1 more outcomes with a free account

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • CHU Angers

    Angers, France

  • Hôpitaux Universitaires de Paris Seine Saint-Denis (HUPSSD, AP-HP),

    Bobigny, France

  • Nouvelle clinique Bel-Air

    Bordeaux, France

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.